Lola Koktysh[email protected]MRIQuantitative imaging biomarkers show promise for NASHQuantitative imaging biomarkers are a promising approach for evaluating normal biological or pathogenic processes, as well as response to treatment and intervention. One near-term clinical application is the assessment of nonalcoholic steatohepatitis (NASH), according to Lola Koktysh of ScienceSoft.March 6, 2017Page 1 of 1Top StoriesCTChest CT muscle attenuation predicts future bone density lossMuscle and bone loss commonly coexist with aging, but potential links between paraspinal muscle and thoracic vertebral bone mineral density loss remain poorly understoodNuclear MedicineCurium gets FDA approval for Lu-177 injection for GEP-NETsMRIBrains age faster among residents in disadvantaged neighborhoodsRadiation Oncology/TherapyASTRO urges CMS to address radiation oncology shortfallsMolecular ImagingCAIX-targeted PET tracer shows promise in patients with ccRCC